DEAR READERS: On July 10, Merck Animal Health said that the U.S. Food and Drug Administration approved its once-yearly injectable product to treat and protect dogs older than 6 months of age from fleas and ticks. Bravecto Quantum is expected to be available soon nationwide. The product was first approved in Australia and New Zealand in 2023, then by the European Union in 2024, and is now approved in more than 50 countries.
Bravecto Quantum’s active ingredient is fluralaner, which works by targeting the nervous systems of insects and parasites, leading to their paralysis and death. Common adverse reactions in field studies include lethargy, decreased appetite, vomiting, diarrhea, elevated liver enzymes and itching.
Fluralaner is part of the isoxazoline class of antiparasitic drugs, a class linked to adverse neurological reactions like tremors, loss of coordination and seizures. Caution is advised for dogs with a history of seizures or neurologic disorders.
There is a growing body of evidence suggesting this class of insecticides may impact the canine gut microbiome, potentially leading to dysbiosis. In some cases, dysbiosis may contribute to the development of food allergies and skin conditions. Research indicates that isoxazolines might reduce the beneficial part of the gut microbiome by 50%, creating an environment where harmful bacteria can thrive.
My concern is that this insecticide only kills fleas, ticks and mosquitos after they have bitten a dog, cat or another treated animal, and therefore does not stop infective insects from transmitting various diseases and triggering allergic reactions.
I use Earth Animal’s Flea and Tick Herbal Bug Spray on my dog -- and on myself -- when we go for walks in our bug-infested woods. It works, and is nontoxic! Earth Animal also has this product as a spot-on, as well as a Daily Internal Powder Supplement to put in pets’ food. The supplement includes ingredients that I have long touted as helpful in repelling biting insects. Such natural products do not contaminate the environment, which is a rising concern when dogs treated with insecticides contaminate lakes and rivers when they go for a dip.
Some insecticides, along with glyphosate-contaminated pet foods, can trigger sudden aggression in dogs. This may be a consequence of the depletion of the "bonding hormone," oxytocin (as detailed in my post here: drfoxonehealth.com/post/antiparasitic-products-and-the-gut-microbiome). From a One Health perspective, I think it would be advisable to check oxytocin levels in persons engaging in acts of violence. Of course, there are multiple factors in the etiology of human aggression, but oxytocin deficiency and its role what I call the empathy deficit disorder should be considered. (For more, see the study "Neurobiology of aggression and violence" by Larry Siever, published in the American Journal of Psychiatry in 2008.)
On July 17, the FDA approved a liquid form of this insecticide -- Exzolt, a fluralaner oral solution -- to be given in the drinking water of poultry for the treatment and control of northern fowl mites in laying hens and replacement chickens.
"In addition to establishing that fluralaner is safe and effective in laying hens and replacement chickens," reads a statement from the agency, "the FDA determined that residues in edible tissues or eggs from birds treated with Exzolt will not represent a public health concern when the product is used according to the label."
The overcrowding of birds in commercial factory farms creates ideal conditions for this mite to spread and infest the entire flock. Less crowding, and the provision of dust-bathing areas that include food-grade diatomaceous earth, would probably prevent the spread of these mites as effectively as insecticides, and with zero risk.
Many avian species regularly dust-bathe, and some engage in reciprocal preening to rid themselves of various external parasites. For details, go to bhwt.org.uk/blog/health-welfare/chicken-dust-bath.
(Send all mail to animaldocfox@gmail.com or to Dr. Michael Fox in care of Andrews McMeel Syndication, 1130 Walnut St., Kansas City, MO 64106. The volume of mail received prohibits personal replies, but questions and comments of general interest will be discussed in future columns.
Visit Dr. Fox’s website at DrFoxOneHealth.com.)